ArticleOncotarget2015

CD163+ tumor-associated macrophage is a prognostic biomarker and is associated with therapeutic effect on malignant pleural effusion of lung cancer patients.

Li Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.